Welcome! If you have a coupon code, click here to apply it. Apply

TRDA $8.13 (+3.44%) Quote details

Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Entrada Therapeutics Inc

NASDAQ | TRDA

8.13

USD

+0.27 (+3.44%)

AT CLOSE (AS OF Apr 17, 2025)

$306M

MARKET CAP

4.839

P/E Ratio

1.68

EPS

$22

52 Week High

$7.1

52 Week Low

LIFE SCIENCES

Sector

TRDA Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

TRDA Technicals

Tags:

TRDA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $211M
Total Revenue $211M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $47M
Selling General And Administrative $38M
Research And Development $125M
Operating Expenses $164M
Investment Income Net -
Net Interest Income $19M
Interest Income $19M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $66M
Income Tax Expense $859K
Interest And Debt Expense -
Net Income From Continuing Operations $66M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda $47M
Net Income $66M

Revenue & Profitability

Earnings Performance

TRDA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $526M
Total Current Assets $440M
Cash And Cash Equivalents At Carrying Value $101M
Cash And Short Term Investments $101M
Inventory -
Current Net Receivables -
Total Non Current Assets $86M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $319M
Other Current Assets $16M
Other Non Current Assets -
Total Liabilities $98M
Total Current Liabilities $39M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $7.6M
Total Non Current Liabilities $58M
Capital Lease Obligations $59M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $59M
Other Current Liabilities $13M
Other Non Current Liabilities -
Total Shareholder Equity $429M
Treasury Stock -
Retained Earnings -$129M
Common Stock $4K
Common Stock Shares Outstanding $39M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$6.2M
Capital Expenditures $3.2M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $103M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $574K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $66M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $211M
Total Revenue $211M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $47M
Selling General And Administrative $38M
Research And Development $125M
Operating Expenses $164M
Investment Income Net -
Net Interest Income $19M
Interest Income $19M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $66M
Income Tax Expense $859K
Interest And Debt Expense -
Net Income From Continuing Operations $66M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda $47M
Net Income $66M

TRDA News

TRDA Profile

Entrada Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None

DMN
9.68%
$0.0034
STSS
20.75%
$0.032
NVDA
-2.87%
$101.49
HTZ
44.31%
$8.24
FMTO
-35.81%
$0.019
RTC
72.09%
$0.37
F
2.45%
$9.63
PLUG
-2.26%
$0.9003
ADGM
92.81%
$1.78
ALTM
0.00%
$5.84
INTC
-1.56%
$18.93
PLTR
1.15%
$93.78
TSLA
-0.07%
$241.37
LGMK
-3.09%
$0.0094
ABEV
3.00%
$2.4
LCID
3.03%
$2.38
AREC
16.22%
$1.29
BTG
-0.90%
$3.32
LYT
-16.78%
$0.0982
PFE
0.45%
$22.14
AAL
0.42%
$9.46
AAPL
1.40%
$196.98
SXTC
118.42%
$2.16
IQ
-2.37%
$1.65
DNN
3.76%
$1.38
BAC
0.21%
$37.41
SOFI
3.00%
$10.98
RIG
5.56%
$2.28
AMZN
-0.99%
$172.61
TLRY
-5.42%
$0.45
JBLU
7.15%
$3.67
GWAV
-26.40%
$0.1628
CHRO
46.61%
$1.84
AGNC
0.48%
$8.34
SMX
57.53%
$2.3
NKLA
-28.74%
$0.183
BTE
4.82%
$1.74
APLD
-3.19%
$3.95
MSGM
145.54%
$2.75
AMD
-0.89%
$87.5
GOOGL
-1.42%
$151.16
PBR
3.57%
$11.62
NVO
-7.63%
$58.08
SNAP
1.81%
$7.88
WBD
2.40%
$8.11
HBAN
3.01%
$13.67
AMCR
1.51%
$9.39
ME
-21.26%
$0.6063
VRN
2.85%
$6.13
CUTR
-10.19%
$0.0969
UNH
-22.38%
$454.11
TSM
0.05%
$151.74
SMCI
-1.21%
$31.505
VALE
1.22%
$9.11
ERIC
2.90%
$8.17
BBD
0.91%
$2.22
T
0.48%
$27.15
LYG
0.00%
$3.76
HOOD
1.28%
$41.18
NGD
-2.67%
$3.64
NIO
0.00%
$3.52
KMI
0.56%
$27.1
KVUE
2.90%
$23.39
AVGO
-2.07%
$170.99
HPE
1.75%
$15.14
AGL
-26.87%
$4
UBER
2.98%
$75.24
CSX
1.21%
$27.68
MRK
2.01%
$78
WMT
2.23%
$93.22
CLSK
3.16%
$7.51
ITUB
1.25%
$5.66
MSFT
-1.03%
$367.78
UUUU
11.74%
$4.95
ACHR
2.55%
$7.23
RIOT
1.57%
$6.46
KO
1.84%
$73
INFY
-2.65%
$16.14
MU
-0.76%
$68.8
QXO
-7.78%
$13.15
MP
-4.46%
$26.35
KGC
-1.53%
$14.8
GOOG
-1.38%
$153.36
MARA
2.76%
$12.66
FNA
0.00%
$13.09
SCHW
0.59%
$76.15
KEY
1.42%
$14.27
WFC
1.14%
$64.71
NKE
4.13%
$55.76
TGL
-25.72%
$2.83
RF
0.73%
$19.31
PTEN
4.12%
$6.07
HIMS
1.04%
$27.23
STLA
2.17%
$9.43
SBSW
1.43%
$4.97
HAL
5.13%
$22.53
IAG
-3.21%
$7.83
XOM
2.62%
$106.92
BABA
1.99%
$108.87
AG
-2.69%
$6.52
DMN
9.68%
$0.0034
STSS
20.75%
$0.032
NVDA
-2.87%
$101.49
HTZ
44.31%
$8.24
FMTO
-35.81%
$0.019
RTC
72.09%
$0.37
F
2.45%
$9.63
PLUG
-2.26%
$0.9003
ADGM
92.81%
$1.78
ALTM
0.00%
$5.84
INTC
-1.56%
$18.93
PLTR
1.15%
$93.78
TSLA
-0.07%
$241.37
LGMK
-3.09%
$0.0094
ABEV
3.00%
$2.4
LCID
3.03%
$2.38
AREC
16.22%
$1.29
BTG
-0.90%
$3.32
LYT
-16.78%
$0.0982
PFE
0.45%
$22.14
AAL
0.42%
$9.46
AAPL
1.40%
$196.98
SXTC
118.42%
$2.16
IQ
-2.37%
$1.65
DNN
3.76%
$1.38
BAC
0.21%
$37.41
SOFI
3.00%
$10.98
RIG
5.56%
$2.28
AMZN
-0.99%
$172.61
TLRY
-5.42%
$0.45
JBLU
7.15%
$3.67
GWAV
-26.40%
$0.1628
CHRO
46.61%
$1.84
AGNC
0.48%
$8.34
SMX
57.53%
$2.3
NKLA
-28.74%
$0.183
BTE
4.82%
$1.74
APLD
-3.19%
$3.95
MSGM
145.54%
$2.75
AMD
-0.89%
$87.5
GOOGL
-1.42%
$151.16
PBR
3.57%
$11.62
NVO
-7.63%
$58.08
SNAP
1.81%
$7.88
WBD
2.40%
$8.11
HBAN
3.01%
$13.67
AMCR
1.51%
$9.39
ME
-21.26%
$0.6063
VRN
2.85%
$6.13
CUTR
-10.19%
$0.0969
UNH
-22.38%
$454.11
TSM
0.05%
$151.74
SMCI
-1.21%
$31.505
VALE
1.22%
$9.11
ERIC
2.90%
$8.17
BBD
0.91%
$2.22
T
0.48%
$27.15
LYG
0.00%
$3.76
HOOD
1.28%
$41.18
NGD
-2.67%
$3.64
NIO
0.00%
$3.52
KMI
0.56%
$27.1
KVUE
2.90%
$23.39
AVGO
-2.07%
$170.99
HPE
1.75%
$15.14
AGL
-26.87%
$4
UBER
2.98%
$75.24
CSX
1.21%
$27.68
MRK
2.01%
$78
WMT
2.23%
$93.22
CLSK
3.16%
$7.51
ITUB
1.25%
$5.66
MSFT
-1.03%
$367.78
UUUU
11.74%
$4.95
ACHR
2.55%
$7.23
RIOT
1.57%
$6.46
KO
1.84%
$73
INFY
-2.65%
$16.14
MU
-0.76%
$68.8
QXO
-7.78%
$13.15
MP
-4.46%
$26.35
KGC
-1.53%
$14.8
GOOG
-1.38%
$153.36
MARA
2.76%
$12.66
FNA
0.00%
$13.09
SCHW
0.59%
$76.15
KEY
1.42%
$14.27
WFC
1.14%
$64.71
NKE
4.13%
$55.76
TGL
-25.72%
$2.83
RF
0.73%
$19.31
PTEN
4.12%
$6.07
HIMS
1.04%
$27.23
STLA
2.17%
$9.43
SBSW
1.43%
$4.97
HAL
5.13%
$22.53
IAG
-3.21%
$7.83
XOM
2.62%
$106.92
BABA
1.99%
$108.87
AG
-2.69%
$6.52
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.